Twist Bioscience (TWST) Cash from Investing Activities (2017 - 2026)

Twist Bioscience (TWST) has reported Cash from Investing Activities for 10 consecutive years, with -$12.7 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Cash from Investing Activities fell 791.02% year-over-year to -$12.7 million; the TTM figure through Mar 2026 stood at -$44.4 million (down 796.31% YoY), while the FY2025 annual figure was -$24.8 million, down 706.32% from the prior year.
• Cash from Investing Activities fell to -$12.7 million in Q1 2026 per TWST's latest filing, from -$9.9 million in the prior quarter.
• Across five years, Cash from Investing Activities topped out at $41.2 million in Q1 2023 and bottomed at -$13.3 million in Q1 2022.
• Historically, Cash from Investing Activities has averaged -$365176.5 across 5 years, with a median of -$1.5 million in 2024.
• Annual changes were most pronounced in 2023 — Cash from Investing Activities soared 409.61% — and 2025, when it sank 1221.66%.
• Twist Bioscience's Cash from Investing Activities stood at -$7.0 million in 2022, then surged by 159.75% to $4.2 million in 2023, then slumped by 136.88% to -$1.5 million in 2024, then sank by 546.68% to -$9.9 million in 2025, then decreased by 27.92% to -$12.7 million in 2026.
• Business Quant data shows TWST's Cash from Investing Activities at -$12.7 million in Q1 2026, -$9.9 million in Q4 2025, and -$12.4 million in Q3 2025.